source
- Biotech Scorecard Q3 Highlights Upcoming Trial Readouts from Amylyx and BiogenSTAT’s quarterly biotech scorecard lists fifteen events that could move biotech stocks, focusing on trial readouts and other milestones. Amylyx Pharmaceuticals reported results from its Phase 3 LU…
- Researchers claim creation of first fully synthetic cell, launch public benefit corporation to share technologyResearchers at the University of Minnesota reported in a preprint that they have built what they call a synthetic cell, dubbed "SpudCell," which they suggest may be the first of its kind. The team…